News | August 22, 2007

Once Yearly Osteoporosis Treatment FDA Approved

August 23, 2007 — The FDA has approved Reclast (zoledronic acid) Injection, the first and only once-yearly treatment for postmenopausal osteoporosis.

Approximately 8 million women in the United States suffer from osteoporosis, a disease characterized by low bone mass and reduced bone strength that causes bones to break easily. Osteoporotic fractures are associated with increased morbidity, mortality and healthcare costs.

The approval was based on efficacy and safety data from a three-year study showing that Reclast reduces the frequency of fractures among areas of the body typically affected by osteoporosis, including the hip, spine and non-spine (i.e., hip, wrist, arm, leg, rib). In the trial, Reclast reduced spine fractures by 70 percent and hip fractures by 41 percent.

Reclast belongs to a class of drugs called bisphosphonates, which are used to treat osteoporosis. Research shows that more than half of women on daily or weekly bisphosphonates for postmenopausal osteoporosis will discontinue treatment at the end of one year, potentially leading to a greater risk of fractures. Unlike other bisphosphonate treatments, Reclast is given as a once-yearly 15-minute infusion.

For more information: www.reclast.com

Related Content

SuperSonic Imagine Introduces Aixplorer Mach 30 Ultrasound at The Liver Meeting
Technology | Ultrasound Imaging | November 14, 2018
SuperSonic Imagine recently exhibited at The Liver Meeting, held Nov. 9-13 in San Francisco, where the company...
New Robotic Arm System Optimizes Testing of Ultrasound Probes

Image courtesy of Esaote

News | Ultrasound Imaging | November 09, 2018
Medical imaging company Esaote and The BioRobotics Institute of Scuola Superiore Sant’Anna in Pisa, Italy, have...
The Acuson Sequoia

The Acuson Sequoia from Siemens Healthineers.

Feature | Ultrasound Imaging | November 05, 2018 | By Jeff Zagoudis
As the world’s most utilized medical imaging modality, ultrasound is likely to be featured heavily at the 2018...
Fujifilm SonoSite Launches New Point-of-Care Ultrasound Educational Resources
News | Ultrasound Imaging | November 01, 2018
Fujifilm SonoSite Inc. announced the launch of its redesigned SonoSite Institute, a comprehensive online educational...
Vygon and Sonoscanner Partnering on New Ultrasound System for Catheter Placement Guidance
News | Cardiovascular Ultrasound | October 31, 2018
Vygon, an international group specialized in single-use medical devices, and French company Sonoscanner announced the...
Cardiac Ultrasound Software Streamlines Fetal Heart Exams
Feature | Cardiovascular Ultrasound | October 30, 2018
A new tool called fetalHQ on GE Healthcare’s Voluson ultrasound systems is the first tool to simultaneously examine the...
Hitachi Supports ASE Foundation Cardiovascular Outreach Mission in West Virginia
News | Cardiovascular Ultrasound | October 29, 2018
Hitachi Healthcare Americas participated in the cardiovascular screening and diagnostic triage event that took place...
Philips Debuts Integrated Breast Ultrasound Solution
News | Ultrasound Women's Health | October 26, 2018
Philips announced what it calls its ultimate ultrasound solution for breast assessment, available with the Philips Epiq...
Samsung Unveils New HERA Ultrasound Systems at ISUOG World Congress 2018

The HERA I10 ultrasound system on display at the ISUOG World Congress 2018. Image courtesy of Samsung Medison.

News | Ultrasound Imaging | October 24, 2018
Samsung Electronics affiliate Samsung Medison is showcasing its new generation of premium ultrasound systems — the HERA...
Nanosonics Trophon2 High Level Disinfection System Available in U.S. and Canada
Technology | Ultrasound Imaging | October 17, 2018
October 17, 2018 — Nanosonics announced the commercial availability of its Trophon2 high level disinfection (HLD) sys